Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of the Oral Microbiome & Mucosal Immunity in COVID-19 Disease: Diagnostic/Prognostic Utility in South Asian Populations

NCT05212766 is registered in ClinicalTrials.gov with King's College London as lead sponsor.

NCT NCT05212766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05212766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of the Oral Microbiome & Mucosal Immunity in COVID-19 Disease: Diagnostic/Prognostic Utility in South Asian Populations
Lead sponsor
King's College London
Phase
Observational
Overall status
Unknown status
Start date
April 7, 2022
Completion date
December 30, 2024
Enrollment
750 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, innate inflammatory response, microbial colonization, mucosal infection, oral disease, periodontal diseases